Learn more

VIROMED CO LTD

Overview
  • Total Patents
    103
  • GoodIP Patent Rank
    61,841
  • Filing trend
    0.0%
About

VIROMED CO LTD has a total of 103 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1999. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are KUMON HIROMI, BIOGENERIX AG and ABIC BIOLOG LAB LTD.

Patent filings per year

Chart showing VIROMED CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kim Jong-Mook 29
#2 Hahn Woong 23
#3 Kim Sujeong 22
#4 Kim Sunyoung 21
#5 Jeong Jae-Gyun 13
#6 Jeong Jae Gyun 13
#7 Park Eun-Jin 13
#8 Yu Seung Shin 11
#9 Kim Jong Mook 9
#10 Kim Seon Hee 7

Latest patents

Publication Filing date Title
WO2019112348A1 Herbal composition for preventing or treating benign prostatic hyperplasia disease
US2019111154A1 Treatment of neuropathy with dna construct expressing hgf isoforms with reduced interference from gabapentinoids
WO2017135791A1 Anti-c-met antibodies and uses thereof
WO2016048105A1 Composition for preventing or treating peripheral vascular disease using hepatocyte growth factor and stromal cell derived factor 1α
KR20170021424A Antibody Specific Aptamer and Use Thereof
CA2926607A1 Composition for preventing or treating amyotrophic lateral sclerosis using two or more isoforms of hepatocyte growth factor
WO2015060650A2 Composition for preventing or treating amyotrophic lateral sclerosis using two or more isoforms of hepatocyte growth factor
WO2015108208A1 Composition for preventing or treating multiple sclerosis, colitis and psoriasis, containing dehydrodiconiferyl alcohol or derivative thereof as active ingredient
WO2013115534A1 Composition for preventing or treating multiple sclerosis
US2013122128A1 Composition comprising an extract of hardy kiwi for preventing or treating baldness disorders or seborrheic skin disorders
EP2784155A1 Adenovirus producing novel cell line and the use thereof
CN109568499A Crude drug composition is used in the treatment of neurological disease and failure of memory improvement
BR112014010594A2 Gene therapy for diabetic neuropathy employing an hgf isoform
WO2010151042A2 Use of schizandra chinensis baillon and chaenomeles sinensis extracts for alleviating muscle fatigue and muscle pain or for enhancing exercise capability
KR20110051246A Biopolymer conjugates comprising an interleukin-11 analog
KR20110038631A Crude drug composition for cartilage regeneration, pain suppression, and edema suppression
EP2281040A2 Lyophilized dna formulations for enhanced expression of plasmid dna
US2009202606A1 Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
KR20090092755A Expression vectors with improved safety
US2006276625A1 Compositions and methods for fusion protein separation